Wide Ranks

ALC

Alcon Inc.

88.23

Top Statistics
Market Cap 43 B Forward PE 26.04 Revenue Growth 5.40 %
Current Ratio 2.57 Trailing PE 37.71 Earnings Growth 29.30 %
Profit Margins 11.89 % Peg Ratio Dividend Yield 0.30 %
Enterprice / EBITA 19.85 Enterprise / Revenue 4.79 Price To Sales Trailing12 Months 4.47
Profitability
Profit Margins 11.89 % Operating Margins 13.53 %
Balance Sheet
Total Cash 1 B Total Cash Per Share 4.01 Total Debt 5 B
Total Debt To Equity 23.96 Current Ratio 2.57 Book Value Per Share 43.24
All Measures
Short Ratio 585.00 % Message Board Id finmb_694234 Shares Short Prior Month 3 M
Return On Equity 0.0559 City Geneva Uuid 56c0bc0e-4758-3068-b969-fbc9797b4361
Previous Close 87.24 First Trade Date Epoch Utc 1 B Book Value 43.24
Beta 0.7300 Total Debt 5 B Volume 1 M
Price To Book 2.04 Fifty Two Week Low 71.45 Total Cash Per Share 4.01
Total Revenue 9 B Shares Short Previous Month Date 1 B Target Median Price 101.83
Audit Risk 1 Max Age 86400 Recommendation Mean 1.64
Sand P52 Week Change 0.3133 Operating Margins 13.53 % Last Dividend Value 0.2640
Target Mean Price 100.20 Net Income To Common 1 B Ask 89.25
Implied Shares Outstanding 495 M Trailing Peg Ratio 320.54 % Last Fiscal Year End 1 B
Average Daily Volume10 Day 1 M Average Volume10days 1 M Total Cash 1 B
Next Fiscal Year End 1 B Revenue Per Share 19.76 Held Percent Insiders 0.0014
Ebitda Margins 24.15 % Dividend Rate 0.2700 Trailing PE 37.71
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 1
Regular Market Previous Close 87.24 Target Low Price 75.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 93.39 Open 88.32 Dividend Yield 0.30 %
Free Cashflow 1 B Return On Assets 0.0255 Time Zone Short Name EST
Board Risk 3 Trailing Eps 2.34 Day Low 87.96
Address1 Chemin de Blandonnet 8 Shares Outstanding 494 M Compensation Risk 7
Price Hint 2 Target High Price 116.00 Website https://www.alcon.com
52 Week Change 0.1666 Average Volume 797914 Earnings Quarterly Growth 28.90 %
Forward Eps 3.52 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 152.90 % Is_sp_500 False Regular Market Day High 88.60
Profit Margins 11.89 % Debt To Equity 23.96 Fifty Two Week High 101.10
Day High 88.60 Shares Short 3 M Regular Market Open 88.32
Industry Key medical-instruments-supplies Bid 85.00 Earnings Growth 29.30 %
Enterprise To Revenue 4.79 Revenue Growth 5.40 % Shares Percent Shares Out 0.0063
Operating Cashflow 2 B Currency USD Time Zone Full Name America/New_York
Market Cap 43 B Is_nasdaq_100 False Zip 1214
Payout Ratio 11.35 % Quote Type EQUITY Industry Medical Instruments & Supplies
Ex Dividend Date 1 B Overall Risk 5 Regular Market Day Low 87.96
Held Percent Institutions 0.6668 Long Name Alcon Inc. Address2 Vernier
Enterprise To Ebitda 19.85 Current Price 88.23 Financial Currency USD
Current Ratio 2.57 Gross Margins 55.50 % Industry Disp Medical Instruments & Supplies
Number Of Analyst Opinions 16 Country Switzerland Float Shares 493 M
Two Hundred Day Average 89.31 Governance Epoch Date 1 B Enterprise Value 46 B
Price To Sales Trailing12 Months 4.47 Forward PE 26.04 Regular Market Volume 1 M
Last Dividend Date 1 B Ebitda 2 B Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide.

The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.

Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery.

Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers.

The company was formerly known as Alcon Universal S.

A.

and changed its name to Alcon Inc. in December 2001.

Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.